Niagen Bioscience ($NAGE) A leader in NAD+ scienceNiagen Bioscience, Inc.BATS:NAGESimeonNikolaev-invest📊 P/E: 28.70 📈 Forward P/E: 26.80 💸 Free Cash Flow: $21.4M 🧠 ROE: 38.9% ⚖️ Debt/Equity: 0.00 📈 Revenue Growth: +36% 📉 PEG: 0.65 ⭐ Analyst: Strong Buy 🎯 In short: A leader in NAD+ science who finally started printing money. Analysts see 135% upside potential to a target price of $15.80. The future of longevity is here. 🧬📈